Xaluritamig by Amgen for Prostate Cancer: Likelihood of Approval

Xaluritamig is under clinical development by Amgen and currently in Phase I for Prostate Cancer.

Clinical Decision Support Solutions Can Prevent 95% Of Medication Errors In The Operating Room

What You Should Know: A new study from Massachusetts General Hospital brings promising news for surgical patients. Researchers have found that specialized computer software can

June 15, 2024

EU poised to reject Amylyx’s ALS drug, as the company vows an appeal

LONDON — European regulators are on the verge of rejecting an ALS drug from Amylyx Pharmaceuticals, all but dooming the medicine’s chances of entering the

June 23, 2023

WHO and Saudi Arabia announce new digital health collaboration to support Hajj pilgrims

The World Health Organization (WHO) and the Kingdom of Saudi Arabia announced a new milestone digital health collaboration today to expand the Hajj health card

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.